Stocks / NASDAQ / Janux Therapeutics Inc.

Janux Therapeutics Inc.

Our Opinion

Janux Therapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“As we have not tested any of our product candidates in humans, and our current data is limited to animal models and preclinical cell lines, theresults of our preclinical studies may not translate into humans and many not accurately predict the safety and efficacy of our product candidates in humans.” (Page 29) Read the full document

Company Description

Janux Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in developing therapeutics based on its Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. Its focus is on developing a class of T cell engagers (TCEs).

Company Website: